Jinling Pharmaceutical Company Limited (SZSE:000919) agreed to acquire 43.6% stake in Nanjing Meishan Hospital Co., Ltd. from Nanjing New Industrial Investment Group Co.,Ltd. and Nanjing Zijin Investment Management Co., Ltd. on January 3, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.53 CNY | +1.71% | -6.18% | -17.03% |
1st Jan change | Capi. | |
---|---|---|
-17.03% | 56Cr | |
+45.82% | 75TCr | |
+40.95% | 63TCr | |
-6.16% | 35TCr | |
+19.86% | 33TCr | |
+9.32% | 30TCr | |
+18.45% | 25TCr | |
+11.88% | 22TCr | |
-0.78% | 22TCr | |
+5.90% | 16TCr |
- Stock Market
- Equities
- 000919 Stock
- News Jinling Pharmaceutical Company Limited
- Jinling Pharmaceutical Company Limited agreed to acquire 43.6% stake in Nanjing Meishan Hospital Co., Ltd. from Nanjing New Industrial Investment Group Co.,Ltd. and Nanjing Zijin Investment Management Co., Ltd.